Fulgent Genetics, Inc.FLGTNASDAQ
Loading
Revenue Growth Recovery in ProgressRecovering
Percentile Rank45
5Y CAGR-59.0%
Studio
Year-over-Year Change

Year-over-year revenue growth rate

5Y CAGR
-59.0%/yr
Long-term compound
Percentile
P45
Within normal range
vs 5Y Ago
0x
Contraction
Streak
2 yr
Consecutive growthRecovering
PeriodValue
202513.83%
2024-1.99%
2023-53.27%
2022-37.64%
2021135.37%
20201196.46%
201952.31%
201814.03%
20172.48%
201690.85%